Showing results (141-150 of 2,576) with videos related to

Sort By:
Pageof 258
Molecular Oncology|April 1, 2022
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3KCristian Prieto-Garcia, Oliver Hartmann, Michaela Reissland, et al.
Molecular Oncology|April 10, 2022
Mesenchymal tumor cells drive adaptive resistance of Trp53-/- breast tumor cells to inactivated mutant KrasLinda J van Weele, Sabra I Djomehri, Shang Cai, et al.
Molecular Oncology|March 21, 2022
KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitorsGuillem Paniagua, Harrys K C Jacob, Oksana Brehey, et al.
Molecular Oncology|September 17, 2018
Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutationsIris F Macheleidt, Priya S Dalvi, So-Young Lim, et al.
Molecular Oncology|October 14, 2018
Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformationHarikrishnareddy Paluvai, Eros Di Giorgio, Claudio Brancolini
Molecular Oncology|February 24, 2022
NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cellsPedro García-Gómez, Irene Golán, Mahsa S Dadras, et al.
Molecular Oncology|March 1, 2022
Pan-cancer analysis reveals sex-specific signatures in the tumor microenvironmentJunwei Han, Yang Yang, Xiangmei Li, et al.
Molecular Oncology|March 17, 2022
A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1α-mediated aerobic glycolysisHsing-I Tseng, Yi-Siang Zeng, Ying-Chung Jimmy Lin, et al.
Molecular Oncology|March 3, 2022
Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experienceBryan H Louie, Shumei Kato, Ki Hwan Kim, et al.
Molecular Oncology|March 5, 2022
Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancyChunfang Hu, Weiwei Jing, Qing Chang, et al.
Pageof 258